drugset / Trial / NCT00108316
Determinants in Antidepressant Outcomes
Withdrawn
US Department of Veterans Affairs
Non-randomizedSingle-groupOpen-label
Summary
This study is designed to understand if a biological measurement, of how platelets respond to serotonin (a chemical in the blood sometimes referred to as SERT), can provide information that will determine an "ideal dose," one specifically tailored for each individual's chemistry. The biological measurement will be obtained by testing a blood sample. There will be approximately 120 control subjects expected for enrollment.
Timeline
- Start
- 2004-01
- Primary completion
- 2005-09
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | — | — |